statistiche ricercatore

TANDA, MARIA LAURA PIERA

Distribuzione geografica

Continente	#
NA - Nord America	9.219
EU - Europa	5.564
AS - Asia	1.112
SA - Sud America	29
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	12
AF - Africa	4
Totale	15.955

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	9.199
IT - Italia	2.894
UA - Ucraina	865
SE - Svezia	596
TR - Turchia	409
VN - Vietnam	336
DE - Germania	329
IE - Irlanda	327
CN - Cina	256
FI - Finlandia	210
GB - Regno Unito	146
FR - Francia	45
JP - Giappone	41
CZ - Repubblica Ceca	34
RU - Federazione Russa	26
IN - India	25
CA - Canada	18
BE - Belgio	15
EU - Europa	14
BR - Brasile	13
CH - Svizzera	13
CL - Cile	13
HK - Hong Kong	13
ES - Italia	12
NL - Olanda	9
AT - Austria	8
NZ - Nuova Zelanda	7
RO - Romania	7
AU - Australia	5
MY - Malesia	5
SG - Singapore	5
BY - Bielorussia	4
HR - Croazia	3
IL - Israele	3
KR - Corea	3
MD - Moldavia	3
PH - Filippine	3
AE - Emirati Arabi Uniti	2
DK - Danimarca	2
EE - Estonia	2
EG - Egitto	2
IR - Iran	2
JO - Giordania	2
MK - Macedonia	2
MX - Messico	2
PT - Portogallo	2
RS - Serbia	2
SK - Slovacchia (Repubblica Slovacca)	2
TH - Thailandia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AR - Argentina	1
BA - Bosnia-Erzegovina	1
BD - Bangladesh	1
BG - Bulgaria	1
GR - Grecia	1
HU - Ungheria	1
IQ - Iraq	1
KW - Kuwait	1
LK - Sri Lanka	1
NG - Nigeria	1
NO - Norvegia	1
PE - Perù	1
PY - Paraguay	1
SI - Slovenia	1
TW - Taiwan	1
TZ - Tanzania	1
Totale	15.955

Salva come PNG Salva come JPEG

Città	#
Milan	2.065
Fairfield	1.424
Woodbridge	841
Ashburn	806
Chandler	748
Jacksonville	690
Houston	662
Seattle	563
Wilmington	530
Cambridge	459
Dearborn	369
Ann Arbor	354
Nyköping	328
Dublin	311
Princeton	307
Izmir	217
Dong Ket	166
Rome	164
San Diego	103
Como	97
San Mateo	79
New York	73
Ogden	62
Washington	55
Redmond	53
Beijing	44
Hefei	39
Tokyo	38
Los Angeles	36
Brno	33
London	33
Helsinki	32
Kunming	32
Boardman	29
Düsseldorf	25
Norwalk	21
Nanjing	18
Frankfurt am Main	17
Berlin	16
Guangzhou	16
Jinan	16
Brussels	15
Munich	12
Varese	12
Nanchang	11
Piacenza	11
Toronto	11
Verona	11
Kilburn	9
Phoenix	9
São Paulo	9
Tappahannock	9
San Francisco	8
Vienna	8
Napoli	7
Shenyang	7
Hong Kong	6
Leinì	6
Paris	6
Pune	6
Redwood City	6
Changsha	5
Chicago	5
Chiswick	5
Dallas	5
Falls Church	5
Kuala Lumpur	5
Mountain View	5
New Bedfont	5
Pavia	5
Prescot	5
Zhengzhou	5
Bangalore	4
Chengdu	4
Fuzhou	4
Lappeenranta	4
Minsk	4
Singapore	4
Wuhan	4
Amsterdam	3
Athis-mons	3
Auckland	3
Carimate	3
Cassano Magnago	3
Chisinau	3
Cormano	3
Edinburgh	3
Hanoi	3
Hebei	3
Kocaeli	3
Livorno Ferraris	3
Madrid	3
Magnago	3
Ningbo	3
Ponte Lambro	3
Quzhou	3
Ronchis	3
Shanghai	3
Stockholm	3
Taizhou	3
Totale	12.296

Salva come PNG Salva come JPEG

Nome	#
Simultaneous medullary and papillary thyroid cancer: two case reports.	196
Pituitary apoplexy during pregnancy: A rare, but dangerous headache	182
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	182
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	179
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?	178
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	175
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study	173
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?	173
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	171
Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature	167
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study	166
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs	165
Continuous monitoring of the recurrent laryngeal nerve in thyroid surgery: a critical appraisal	164
Physical performance in newly diagnosed hypothyroidism: a pilot study	161
Skeletal health in patients with differentiated thyroid carcinoma	161
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity	159
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	155
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	155
Breast cancer and thyroid diseases: analysis of 867 consecutive cases	154
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?	154
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)	151
Minimally invasive follicular thyroid cancer (MIFTC) - A consensus report of the European Society of Endocrine Surgeons (ESES)	150
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study	148
Can a patient-tailored treatment approach for Graves' disease reduce mortality?	147
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.	145
Pituitary in black—hypopituitarism secondary to hemosiderosis	145
Shortening Hospital Stay for Thyroid Surgery.	143
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction	142
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study	141
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association	139
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial	139
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature	138
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy	136
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal	136
Medullary thyroid carcinoma: surgical treatment advances	136
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography	133
Treating Graves' orbitopathy: where are we?	131
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	131
Orbital radiotherapy for Graves' ophthalmopathy	130
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose?	130
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy	129
Multidisciplinary Management of Intrathoracic Goiter: A Case Report	129
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study	127
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations	127
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center	127
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy	126
Relationship between management of hyperthyroidism and course of the ophthalmopathy	126
Radioiodine and thyroid-associated ophthalmopathy	126
Cigarette smoking and the thyroid	125
Orbital radiotherapy for Graves' ophthalmopathy	124
Medullary thyroid carcinoma: surgical treatment advances	124
Efficacy and safety of orbital radiotherapy for Graves' orbitopathy	122
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography	121
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group	121
Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives.	121
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives	121
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?	120
Orbital radiotherapy for Graves' ophthalmopathy	120
Recent developments in the follow-up, prevention and management of complications in thyroid surgery	120
Novel approaches to the management of Graves' ophthalmopathy	119
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions	118
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying	118
La prevenzione dell'oftalmopatia basedowiana	117
An update on medical management of Graves' ophthalmopathy	117
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy	116
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications	115
Management of thyroid eye disease	115
Currently available somatostatin analogs are not good for Graves' orbitopathy	114
Novel immunomodulating agents for Graves orbitopathy	114
An update on the pharmacological management of hyperthyroidism due to Graves' disease	113
Orbital decompression in Graves' ophthalmopathy by medial and lateral wall removal	113
Thyroid autoimmunity and environment	112
Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter.	111
The iodine nutritional status in the Italian population: data from the Italian National Observatory for Monitoring Iodine Prophylaxis (OSNAMI) (period 2015–2019)	110
Thyroid cancer with tracheal invasion: A pathological estimation	108
Graves' ophthalmopathy	108
Prevalence and natural history of Graves' orbitopathy in the XXI century	107
Novel treatment modalities for Graves' orbitopathy	103
Amiodarone and the thyroid	103
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European Endocrinologists	102
Influence of new technologies on thyroid surgery: state of art	100
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement.	98
Smoking and the Thyroid	96
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	95
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study	95
Simultaneous Occurrence of Multicentric Medullary and Papillary Thyroid Cancer: A Case Report	94
La prevenzione della oftalmopatia basedowiana	90
Ectopic submandibular thyroid tissue with a coexisting normally located multinodular goitre: case report and review of the literature.	89
Amiodarone-unduced thyrotoxicosis. A review	89
Oxidative stress and Graves' ophtalmopathy: in vitro studies and therapeutic implications	88
Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis as compared to subacute thyroiditis	87
When primary hyperparathyroidism comes as good news	87
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?	87
Terapia e follow-up dell'ipertiroidismo	85
Image-guided thyroid nodule ablation: technical notes and critical appraisal	85
Amyloid goiter	85
Intravenous (IV) and oral (OR) glucocorticoid therapy in patients with severe Graves’ ophthalmopathy (GO): results of a randomized, single-blind, prospective study	84
Analisi dei costi	84
Graves’ Ophthalmopathy and 131-I therapy	82
Thyroid Hormone Receptors	82
Totale	12.652

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	61.907
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	61.907

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	493	0	0	0	0	0	0	0	0	0	0	0	493
2019/2020	3.271	134	107	156	601	281	432	485	379	253	208	43	192
2020/2021	2.746	42	210	120	232	107	319	262	297	369	171	245	372
2021/2022	1.866	177	170	90	78	113	145	120	90	248	297	131	207
2022/2023	2.246	274	140	174	235	159	496	16	270	276	85	53	68
2023/2024	3.651	537	541	550	661	656	347	23	47	108	51	17	113
Totale													16.234